CRISPR Therapeutics AG (CRSP)
55.08
+2.70
(+5.15%)
USD |
NASDAQ |
May 06, 16:00
54.81
-0.27
(-0.49%)
After-Hours: 05:26
CRISPR Therapeutics Profit Margin (Quarterly) : -8.43K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 34.24% |
| Beam Therapeutics, Inc. | -- |
| Novartis AG | 24.07% |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -30.92% |
| Return on Assets | -24.87% |
| Return on Invested Capital | -26.24% |
| Gross Profit Margin (Quarterly) | -3.35K% |
| Operating Margin (Quarterly) | -8.93K% |
| Return on Net Operating Assets | -222.7% |